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Introduction
Tenascin-C (TN-C) is a six-armed extracellular matrix glycoprotein initially discovered at the myotendinous junction 1, 2 . It is a member of a family of related proteins comprising TN-C, -R, -X, and -Y 1-3 . Tenascins have a modular composition with an amino-terminal oligomerization domain consisting of heptad repeats, multiple epidermal growth factor (EGF)-like repeats, a variable number (from 8 to 14) of fibronectin type III modules, and a carboxyl-terminal fibrinogen-like globular domain 4 . The heptad repeat sequences facilitate the formation of hexamers, in which form TN-C is deposited in the tissues 1, 2 . It interacts with other ECM molecules such as integrins, collagens, proteoglycans, heparin, syndecan, and fibronectin. It plays a major role in cell adhesion, migration, proliferation, and cellular signaling 5 . In addition, TN-C acts as an elastic protein that can stretch to several times its resting length by stretch-induced unfolding of its fibronectin type III domains 6 .
TN-C is abundantly expressed in musculoskeletal tissues during organogenesis and embryogenesis, while its expression is very restricted in healthy tissues, and reappears as a high molecular weight splice variant in association with wound healing, inflammatory processes, or neoplasia 7, 8 . TN-C is associated with the development of articular cartilage, but decreases markedly during maturation of chondrocytes 9,10 , and almost disappears in adult cartilage 11, 12 . TN-C is highly re-expressed in the cartilage and the synovium of diseased or injured joints [11] [12] [13] [14] [15] . There is a correlation between the levels of TN-C in joint fluids and degree of cartilage degradation 16 or radiographic severity of OA 17 . It stimulates the production of proinflammatory cytokines in human macrophages and synovial fibroblasts through activation of Toll-like receptor-4 (TLR4) 18 .
We have shown elevated levels of TN-C in joint fluid in animal models of joint disease, and demonstrated the capacity of TN-C to induce inflammatory mediators and matrix degradation in vitro in human joint cartilage 19 . The objective of the present study was to determine the levels of TN-C in synovial fluid of patients with joint injury and joint disease, and to correlate levels of TN-C with markers of cartilage matrix degradation and inflammation in the same fluids. TN-C levels were also examined in synovial fluids of a dog model of joint injury.
Methods

Human synovial fluid samples
Human knee synovial fluids (n=164) were aspirated without lavage from a cross-sectional convenience cohort with informed consent and approval of the Lund University Research Ethics Committee. Diagnosis was made by arthroscopy, radiography, assessment of joint fluid and clinical examination. Diagnostic groups were knee healthy references without current or past knee symptoms or injury (REF), acute inflammatory arthritis (pseudogout, pyrophosphate crystal arthritis, AIA), knee anterior cruciate ligament rupture with or without concomitant meniscus lesions (ACL), isolated knee meniscus lesions (MEN), and knee osteoarthritis (OA) ( Table 1 ). The OA grades of these groups were based on combined arthroscopic and radiographic data as described 20 
Dog knee joint instability model
Instability surgery was performed in 9.6 (9.1 -9.9 range) month old skeletally mature, purpose-bred male cross-bred hounds (Marshall Farms, New Rose NY) weighing 19.4 kg (17.1 -21.9 kg range) in Massachusetts and Pearl River Pfizer (formerly Wyeth) Institutional Animal Care and Use Committee (IACUC)-approved protocols. Dogs were anesthetized with isoflurane and pre-operative radiographs obtained to ensure that no radiographic joint abnormalities were present before instability induction. Fentanyl patches were applied preoperatively and kept in place for 3 days to provide sustained post-operative pain relief.
Anterior cruciate ligament (ACLT) is an established instability model of OA induction in dogs 21, 22 17, 19, 23 . Samples were diluted in PBS before being assayed following the manufacturer's protocol.
Other biomarkers and assays
The human joint fluid samples assayed for TN-C in the present study were obtained in the course of previous studies, and assay results for the F21-epitope of aggrecan, 846 epitope of aggrecan, cartilage oligomeric matrix protein (COMP), type II collagen cross-linked Ctelopeptide fragments (CTX-II), procollagen II C-propeptide (PCIIC), matrix metalloproteinase (MMP) 1, MMP-3, tissue inhibitor of matrix metalloproteinases 1 (TIMP-1), MMP-1-activity, and MMP-3-activity were in part published in the course of these studies [24] [25] [26] [27] [28] [29] [30] [31] [32] . Immunoassays were performed as described for ARG-neoepitope aggrecan fragments 24, 25 , aggrecan epitopes using the 1-F21 and the 846 monoclonal antibodies 24, 26 , COMP, CTX-II, PCIIC, MMP-1, MMP-3, and TIMP-1 [27] [28] [29] [30] . Synovial fluid MMP-1 and -3 proteinase activities were assayed as described 32 .
Statistical methods
Data were analyzed using Sigmaplot 12 and STATA 12.1. Biomarker concentrations were not normally distributed and were therefore logarithmically transformed for statistical analysis, following which values were normally distributed by Shapiro-Wilk's test, allowing parametric tests for diagnostic group differences by one-way ANOVA with Holm-Sidak correction for multiple comparisons against the reference group. The influence of OA grade, gender, age and sampling time after injury or onset of symptoms on TN-C concentrations in human diagnostic groups was analyzed by multiple linear regression analysis. To explore the influence of time between injury and sampling on TN-C concentration in synovial fluids, the diagnostic groups ACL and MEN were merged, and samples ordered by time windows as in Figure 1) . Concentrations in the AIA, ACL, MEN and OA groups were on average fold increased over the mean reference group value by 10.9 (95% confidence intervals 5.3, 22.5), 5.0 (2.7, 9.1), 3.5 (2.8, 6.4) and 6.2 (2.8, 14.0), respectively. When the influence on TN-C levels of age, gender, OA-grade and time between synovial fluid sampling and injury or onset of symptoms was examined for the full sample set (n=164), only time between sampling and injury or onset of symptoms showed a statistically significant relationship with TN-C concentrations in synovial fluid (p=0.004). Accordingly, after injury to the anterior cruciate ligament, meniscus or both, TN-C levels increased markedly in the acute phase, with a maximum of an almost 7-fold increase over the mean reference level between 0 and 12 weeks in the ACL group. With increasing time after joint injury concentrations decreased, but were statistically significantly increased over the REF group at all time windows studied, even beyond one year after injury (p<0.001, Figure 2 ). At 6 months following ACLT surgery, the operated dog joints showed both macroscopic and histological signs of early stage osteoarthritis in the ACL-deficient joint (Figure 3) . Similar to the injured human knee joints, TN-C was also increased at all time points in the synovial fluid of the knee of the dogs that underwent ACLT surgery when compared to the fluids of the contralateral sham operated left knee ( Table 2 ). In parallel with the human ACL or meniscus injured knees, the dog ACLT knees showed a 68-fold (31.8, 146.1) increase of TN-C at 1 month after ACL transection that declined to around 52-and 49-fold increases at 3 and 6 months after surgery as compared to the contralateral sham-operated knees.
Synovial fluid levels of TN-C in the human samples were statistically significantly correlated with several biomarkers proposed to reflect joint tissue turnover ( Table 3) . Notably, TN-C levels were well correlated with levels of aggrecanase-dependent ARG-aggrecan fragments and type II collagen cross-linked C-telopeptides, less well with aggrecan epitope F21 (lacking specificity for aggrecan proteolytic fragments), but not at all with COMP or PCIIC. Further correlations were noted with the 846 aggrecan epitope, and with protein levels of MMP-1, MMP-3 and TIMP-1, as well as with activity levels of MMP-1 and MMP-3 proteinases.
Discussion
We have found highly increased levels of TN-C in joint fluids following knee injury in humans and in an analogous dog joint injury model, as well as in samples of joint fluid from patients with acute joint inflammation or osteoarthritis. The TN-C levels correlated with several synovial fluid biomarkers that are suggested to reflect joint tissue degradation and repair.
Our results confirm and markedly extend previous reports on the presence of TN-C in human synovial fluids from patients with OA and rheumatoid arthritis 16, 17, 33 . We found the highest average TN-C concentrations in samples from patients with acute inflammatory arthritis, and note that following human knee joint injury, levels were 7-fold increased in the acute injury phase and more than 3-fold increased even at times longer than 1 year after injury, compared with the reference group. Similar to human joint injury, TN-C levels in dog synovial fluids were greatly increased shortly after injury, and remained elevated for at least 6 months following the joint insult.
Our results are also consistent with previous work showing an increased expression of TN-C in human and animal OA cartilage 19, 34 , and an increased presence of TN-C in damaged and OA cartilage determined by immunohistochemistry [11] [12] [13] [14] 35, 36 .
The cell or tissue source of the TN-C in human or dog synovial fluids in the present study is uncertain, but a local contribution by chondrocytes and synovial cells of the injured joint is likely, given that previous work has documented the production of TN-C by these cells and in cartilage explants when stimulated by proinflammatory cytokines 14, 18, 19 . The most marked expression increases related to dedifferentiation of chondrocytes were shown for TN-C, type I collagen and hypoxia-inducible factor 1-alpha (HIF-1α) 37 . This does not exclude a systemic contribution to the synovial fluid levels of TN-C. Large (350 and 240kD) and small (210 kD) variants of TN-C have been detected by us and others in human OA synovial fluids 17, 19, 33 , but information on the detailed structure or the mechanism of release of TN-C and TN-C fragments into synovial fluid is lacking. We have earlier reported that both large and small variants were abundant in OA cartilage and synovial fluids when compared to non-OA samples; we found fragments of TN-C of molecular weight lower than 200 kD only in OA cartilage and synovial fluid 19 . Our findings in OA cartilage were later confirmed by the finding that smaller fragments <200 kD are specific to diseased tissue and induce aggrecanase activity 36 . These specific fragments could be MMP generated as large variants are known to be more susceptible to MMP cleavage such as MMP-2 and MMP-7 38 . Considering the low content of TN-C in normal adult articular cartilage, a significant part of the marked increase of TN-C in joint fluid after injury probably represents the product of an upregulated TN-C expression by chondrocytes and synoviocytes. The marked increases of synovial fluid TN-C levels found both after dog and human joint injury and in human OA are thus consistent with, and may serve as a marker of a local upregulation of inflammation pathways, and possibly a dedifferentiation of chondrocytes, in these conditions. The Toll-like receptor-4 (TLR4) is present on human chondrocytes and the TLR4 expression increases with increasing degree of OA cartilage damage 39 . Interestingly, it was shown that TN-C is an endogenous activator of TLR4 and that mice lacking TLR4 are protected from erosive arthritis in a model of inflammatory arthritis 18 . Recent evidence further suggests that synovial dendritic cells may be activated by TN-C, driving IL-17 synthesis in a murine arthritis model 40 . Exposure to exogenous TN-C induced expression of proinflammatory cytokines in synovial explants, macrophages and synoviocytes from individuals with rheumatoid arthritis via activation of TLR4, and elicited dose-dependent joint inflammation in mice 18 . Thus, TN-C fulfills the criteria for an endogenous proinflammatory molecule generated in damaged tissue (damage associated molecular patterns, DAMPs), which through activation of TLR4 mediates persistent inflammation and tissue destruction 18, 41 . Consistent with these findings, recent studies report that TN-C fragments, but not full length TN-C, induce expression of ADAMTS4 and a dose dependent release of aggrecanase-generated ARG-aggrecan fragments from the matrix in OA cartilage 36 .
The findings briefly summarized here on the role of TN-C through activation of TLR4, with a focus on inflammatory joint disease, suggest that the high concentrations of TN-C we have detected being released into human joint fluids after joint injury and in OA may serve to induce and prolong inflammation and matrix degradation also in these conditions. Activation of TLR through DAMPs such as TN-C may be particularly relevant in the acute phase after joint injury. The correlations noted in this study between TN-C on the one hand, and aggrecanase-generated ARG-aggrecan fragments, type II collagen C-telopeptides, and MMP protein content and protease activity on the other hand, add further support to this hypothesis.
We have in the present study not demonstrated a direct relationship between TN-C fragment generation and aggrecanase or MMP activity. However, large variants of TN-C have been shown to be susceptible to MMP cleavage 38 , and human cartilage subjected to digestion with aggrecanase generates cleaved TN-C peptides that map to the N-terminal assembly domain, suggesting that the generation of TN-C fragments by proteases may stimulate proteases and in turn a positive feedback loop of further cartilage matrix degradation 42 .
Our study has some limitations, notably in the use of a cross-sectional sample collection of human and canine samples to illustrate time-related events after joint injury. We further acknowledge that validation of the TN-C assay is limited with regard to its specificity and the TN-C variants recognized. In the dog study, we used the contra-lateral knee of the same animal as a control. The bias associated with the use of a 'contra-lateral control joint' is difficult to predict. Firstly, the contra-lateral control joint may be systemically affected by the surgical procedure on the index joint, and may also be affected by changes in joint loading due to the defective index joint. The resulting bias on any 'between-sides' differences are difficult to predict but could serve to decrease apparent differences between the index and control joints. We have interpreted biomarker results based on concentrations in synovial fluid, without consideration of likely variations in synovial fluid and biomarker clearance between different diagnostic groups and different disease phases. As clearance increases with joint inflammation, biomarker concentrations are confounded with regard to their relationship with actual joint tissue biomarker release 43 .
In conclusion, TN-C fragments released into synovial fluid after joint injury and in OA may serve as a biomarker of inflammation and chondrocyte dedifferentiation, and at the same time act to induce and prolong inflammation in these conditions. However, intact TN-C in the cartilage appears to have a role in matrix formation, development and repair, and interacts with the aggrecan G3 domain 9,10,44-45 , and deficiency of TN-C in knock-out mice is associated with accelerated development of OA and delayed repair of cartilage damage 46 . Further work is needed to fully understand the consequences of the up-regulated synthesis of TN-C, its fragmentation and release into joint fluid after joint injury and in osteoarthritis. Table 1 Details of patients and volunteers that provided synovial fluid samples Table 2 ACLT: anterior cruciate ligament transection surgery knee, ContL: contralateral sham operated knee, m: month. Mean TN-C is the mean of the average TN-C values for subjects/animals within a group tested in triplicates. Abbreviations: ARG-aggrecan, ARG-neoepitope of aggrecanase cleaved aggrecan; F-21 aggrecan, F-21 monoconal antibody epitope of aggrecan; 846 aggrecan, 846 epitope of aggrecan; COMP, cartilage oligomeric matrix protein; CTX-II, type II collagen crosslinked C-telopeptides; PCIIC, type II collagen C-propeptide; MMP-1, -3, matrix metalloproteinase, TIMP-1, tissue inhibitor of matrix metalloproteinase-1. Variable numbers of assay data are a consequence of variable limitations in sample volume. 
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TN-C protein in dog knee synovial fluid
